Finerenone

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1166 publications

Pharmacokinetics of novel drugs for the treatment of Diabetic nephropathy.

Pharmacokinetics of novel drugs for the treatment of Diabetic nephropathy.

Journal: Expert opinion on drug metabolism & toxicology
Published: September 08, 2026

In adults with CKM syndrome, finerenone vs. placebo reduced sudden death at a median 2.9 y.

In adults with CKM syndrome, finerenone vs. placebo reduced sudden death at a median 2.9 y.

Journal: Annals of internal medicine
Published: August 31, 2026

Sex in CKD trials: representation and treatment effects of cardiorenoprotective therapies.

Sex in CKD trials: representation and treatment effects of cardiorenoprotective therapies.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 31, 2026

Efficacy and safety of finerenone in adults with IgA nephropathy: a 12-month real-world study.

Efficacy and safety of finerenone in adults with IgA nephropathy: a 12-month real-world study.

Journal: Renal failure
Published: August 24, 2026

Finerenone Plus Empagliflozin: How Low Can We Go, and How Much Does Blood Pressure Matter?

Finerenone Plus Empagliflozin: How Low Can We Go, and How Much Does Blood Pressure Matter?

Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 19, 2026

Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.

Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.

Journal: Journal of cardiovascular pharmacology
Published: August 19, 2026

Finerenone use and incident psoriasis in patients with type 2 diabetes and chronic kidney disease: A retrospective cohort study using the TriNetX network.

Finerenone use and incident psoriasis in patients with type 2 diabetes and chronic kidney disease: A retrospective cohort study using the TriNetX network.

Journal: JAAD international
Published: August 14, 2026

Individualizing pharmacologic and non-pharmacologic therapy for CKD associated with diabetes.

Individualizing pharmacologic and non-pharmacologic therapy for CKD associated with diabetes.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 08, 2026

New Evidence in Heart Failure: 2026 Update.

New Evidence in Heart Failure: 2026 Update.

Journal: ESC heart failure
Published: August 07, 2026

MRAs and Race in Heart Failure: An Individual Participant Data Meta-Analysis of Randomized Trials.

MRAs and Race in Heart Failure: An Individual Participant Data Meta-Analysis of Randomized Trials.

Journal: Circulation. Heart failure
Published: August 07, 2026

Targeting kidney disease in type 1 diabetes: progress and promise.

Targeting kidney disease in type 1 diabetes: progress and promise.

Journal: Expert review of endocrinology & metabolism
Published: August 06, 2026

Consensus Guidance for the Diagnosis and Management of Diabetic Kidney Disease: Executive Summary.

Consensus Guidance for the Diagnosis and Management of Diabetic Kidney Disease: Executive Summary.

Journal: The Journal of the Association of Physicians of India
Published: August 03, 2026
Showing 1-12 of 1,166

Last Updated: 09/26/2026